At two international meetings -- the Americas Committee for Treatment and Research in Multiple Sclerosis ... said HERCULES ...

Researchers have developed tiny, wireless devices capable of wrapping around individual neurons, potentially aiding in the ...

Austin, Nov. 11, 2024 (GLOBE NEWSWIRE) --“According to S&S Insider, The Neuroscience Market Size was valued at USD 35.3 ...

Three providers of The South Jersey MS Center have all been reviewed and approved by NJ Top Docs based on merit for 2024. AUDUBON, ...

IVX Health, a national provider of outpatient infusion and injection centers, today announced the opening of two additional infusion centers in New Jersey. Conveniently located in the greater North ...

CVN293 was generally well-tolerated in healthy volunteers for up to 14-days of continuous dosingDose-dependent exposure was ...

The Phase II clinical trial (NCT05116540) is a balanced randomized, double-blind, single center study that enrolled 24 participants, 12 in the treatment group and 12 in the placebo. The study ...

Dr. Robert Zivadinov, The Boston Home’s Alex Burnham, and members of the MS study advisory council attended last Wednesday’s press conference. Researchers say they are close to a medical breakthrough ...

Silvana Lopes Costa, PhD, of Kessler Foundation was awarded the prestigious Women in Neurodegenerative Disease Rehabilitation ...

The test’s ability to distinguish ALS from similar conditions is particularly noteworthy. It could help physicians differentiate between ALS and conditions that mimic its symptoms, such as primary ...

In a study of commonly used treatments for people with multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in meaningful improvements in fatigue ...